| Monica Ashley Wilder, | |
|
2101 N Van Buren St, Enid, OK 73703-2524 | |
| (580) 297-9993 | |
| Not Available |
| Full Name | Monica Ashley Wilder |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 2101 N Van Buren St, Enid, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144877341 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Flexcare Infusion Okc, Llc | 3870826118 | 4 |
News Archive
When Sherry Wittenberg was diagnosed with a rare cancer in the cricoid cartilage of her larynx, doctors told her the only way to treat the condition was to remove her voice box. The operation would leave her unable to speak normally and would require her to breathe through a hole in her neck for the rest of her life.
Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors. Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.
Specific variants in genes that encode proteins regulating inflammation may hold a key to explaining a host of disease processes known to cause increased risk of illness and death among African Americans, according to a study from the University of Pittsburgh's Graduate School of Public Health (GSPH).
University of Sydney researchers have found that heavy snorers have a higher risk of cholesterol plaque in the neck arteries, leading to an increased risk of stroke.
New years often bring New Year's resolutions, and while most don't last through the year, one regional physician group decided to make 2009 a year of new social media marketing initiatives. Southeast Anesthesiology Consultants' (SAC) commitment to two-way conversations on the Internet began in January and has continued throughout 2009 with remarkable success.
› Verified 9 days ago
| Entity Name | Williams Medical Group Practice Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346608809 PECOS PAC ID: 3375832157 Enrollment ID: O20181228001300 |
News Archive
When Sherry Wittenberg was diagnosed with a rare cancer in the cricoid cartilage of her larynx, doctors told her the only way to treat the condition was to remove her voice box. The operation would leave her unable to speak normally and would require her to breathe through a hole in her neck for the rest of her life.
Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors. Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.
Specific variants in genes that encode proteins regulating inflammation may hold a key to explaining a host of disease processes known to cause increased risk of illness and death among African Americans, according to a study from the University of Pittsburgh's Graduate School of Public Health (GSPH).
University of Sydney researchers have found that heavy snorers have a higher risk of cholesterol plaque in the neck arteries, leading to an increased risk of stroke.
New years often bring New Year's resolutions, and while most don't last through the year, one regional physician group decided to make 2009 a year of new social media marketing initiatives. Southeast Anesthesiology Consultants' (SAC) commitment to two-way conversations on the Internet began in January and has continued throughout 2009 with remarkable success.
› Verified 9 days ago
| Entity Name | Flexcare Infusion Okc, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013480490 PECOS PAC ID: 3870826118 Enrollment ID: O20190531001347 |
News Archive
When Sherry Wittenberg was diagnosed with a rare cancer in the cricoid cartilage of her larynx, doctors told her the only way to treat the condition was to remove her voice box. The operation would leave her unable to speak normally and would require her to breathe through a hole in her neck for the rest of her life.
Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors. Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.
Specific variants in genes that encode proteins regulating inflammation may hold a key to explaining a host of disease processes known to cause increased risk of illness and death among African Americans, according to a study from the University of Pittsburgh's Graduate School of Public Health (GSPH).
University of Sydney researchers have found that heavy snorers have a higher risk of cholesterol plaque in the neck arteries, leading to an increased risk of stroke.
New years often bring New Year's resolutions, and while most don't last through the year, one regional physician group decided to make 2009 a year of new social media marketing initiatives. Southeast Anesthesiology Consultants' (SAC) commitment to two-way conversations on the Internet began in January and has continued throughout 2009 with remarkable success.
› Verified 9 days ago
| Entity Name | Signify Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689158487 PECOS PAC ID: 3274895263 Enrollment ID: O20210505002298 |
News Archive
When Sherry Wittenberg was diagnosed with a rare cancer in the cricoid cartilage of her larynx, doctors told her the only way to treat the condition was to remove her voice box. The operation would leave her unable to speak normally and would require her to breathe through a hole in her neck for the rest of her life.
Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors. Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.
Specific variants in genes that encode proteins regulating inflammation may hold a key to explaining a host of disease processes known to cause increased risk of illness and death among African Americans, according to a study from the University of Pittsburgh's Graduate School of Public Health (GSPH).
University of Sydney researchers have found that heavy snorers have a higher risk of cholesterol plaque in the neck arteries, leading to an increased risk of stroke.
New years often bring New Year's resolutions, and while most don't last through the year, one regional physician group decided to make 2009 a year of new social media marketing initiatives. Southeast Anesthesiology Consultants' (SAC) commitment to two-way conversations on the Internet began in January and has continued throughout 2009 with remarkable success.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Monica Ashley Wilder, 1001 W Memorial Rd Ste 112, Oklahoma City, OK 73114-2000 Ph: (405) 509-6599 | Monica Ashley Wilder, 2101 N Van Buren St, Enid, OK 73703-2524 Ph: (580) 297-9993 |
News Archive
When Sherry Wittenberg was diagnosed with a rare cancer in the cricoid cartilage of her larynx, doctors told her the only way to treat the condition was to remove her voice box. The operation would leave her unable to speak normally and would require her to breathe through a hole in her neck for the rest of her life.
Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors. Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.
Specific variants in genes that encode proteins regulating inflammation may hold a key to explaining a host of disease processes known to cause increased risk of illness and death among African Americans, according to a study from the University of Pittsburgh's Graduate School of Public Health (GSPH).
University of Sydney researchers have found that heavy snorers have a higher risk of cholesterol plaque in the neck arteries, leading to an increased risk of stroke.
New years often bring New Year's resolutions, and while most don't last through the year, one regional physician group decided to make 2009 a year of new social media marketing initiatives. Southeast Anesthesiology Consultants' (SAC) commitment to two-way conversations on the Internet began in January and has continued throughout 2009 with remarkable success.
› Verified 9 days ago